19 Mar 2014 15:09
ViaLogy PLC ("ViaLogy" or "the Company")
Replacement announcement: Grant of options
Vialogy has made an amendment to the "Grant of options" announcement released on 19 March 2014 at 12:25 p.m. under RNS no. 6935C. The amendment is underlined. All other details remain unchanged and the full amended text is shown below.
The remuneration committee of ViaLogy PLC confirm the grant of options as detailed in the circular to shareholders dated 7 January 2014 ("the Circular") as follows:
Director | Options |
Adam Reynolds | 59,166,666 |
Nick Mustoe | 59,166,666 |
Mark Collingbourne | 59,166,666 |
Sandeep Gulati | 38,503,632 |
Robert Dean | 23,996,368 |
These options have been granted under the New Share Scheme (as defined in the Circular) and are exercisable at a price of 0.1p per share but will only vest if the Company's share price reaches or exceeds 0.5p for a continuous period of 30 days at any time during the period of five years from 28 January 2014.
For further information:
ViaLogy PLC
Mark Collingbourne
mark.collingbourne@vialogy.com
Nominated Advisor to ViaLogy PLC (Cantor Fitzgerald Europe)
Mark Percy / Catherine Leftley - Corporate Finance +44 (0) 207 894 7000